Welcome to our dedicated page for Bed, Bath & Beyond SEC filings (Ticker: BBBY), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Bed Bath & Beyond, Inc. filings document an ecommerce-focused retailer’s operating results, material agreements, acquisition activity, governance matters, and capital structure. Form 8-K reports include quarterly and annual financial-result releases, material definitive agreements, completion reports for acquisitions such as The Brand House Collective, executive appointments, compensation arrangements, and other corporate events.
Proxy and registration-related filings cover annual meeting proposals, director elections, auditor ratification, say-on-pay matters, charter amendments, equity-plan matters, shareholder voting mechanics, and disclosures tied to common stock and warrants. The filing record also addresses the company’s brand portfolio, retail execution, technology and administrative costs, risk factors, and public-company governance.
Bed Bath & Beyond, Inc. updated its dealings with The Brand House Collective, Inc. on September 15, 2025. The company amended its existing term loan credit agreement to add new delayed-draw term loan commitments with an aggregate original principal amount of $20 million, which the company can convert into equity of The Brand House Collective, up to 75% of its outstanding common stock, under agreed conditions.
The company also amended its asset purchase agreement for the Kirkland’s brand, increasing the total purchase price from $5.233 million to $10 million for trademarks, domain names, and related brand assets, paid at closing on September 15, 2025. At the same time, Bed Bath & Beyond amended the existing trademark license so The Brand House Collective can continue using the Kirkland’s brand for its current stores, websites, and products, including an exclusive license for existing brick-and-mortar stores that lasts until the earlier of September 15, 2027 or the rebranding or closure of all such stores.
Bed Bath & Beyond, Inc. announced a warrant dividend to its common shareholders. Investors of record as of the close of business on October 2, 2025 will receive warrants to purchase additional common shares.
Each holder will receive one warrant for every ten shares of common stock, rounded down, with an exercise price of $15.50 per share. The warrants are expected to be distributed on or around October 7, 2025 and will expire on October 7, 2026. The company intends to apply to list the warrants on the New York Stock Exchange under the symbol BBBYW, allowing them to trade separately.
The company plans to file a Form 8-A registration statement and a prospectus supplement describing the warrant terms, and it has posted a detailed FAQ for investors. The communication clarifies that the warrant dividend itself is not an offer or sale of securities under the Securities Act.
Brand House Collective, Inc. (TBHC) disclosed an amendment to a Schedule 13D showing Bed Bath & Beyond, Inc. beneficially owns 13,404,280 shares, representing 49.8% of the outstanding common stock based on 22,461,383 shares outstanding as of September 9, 2025. Bed Bath & Beyond amended its credit arrangements with the issuer on September 15, 2025, by committing to $20.0 million of delayed-draw term loan commitments evidenced by convertible Delayed Draw Notes. The Delayed Draw Notes and existing Notes can convert into 4,469,815 shares currently exercisable, equal to 19.9% of outstanding shares. The credit amendments also adjust a change-of-control threshold from 65% to 75%.
Brand House Collective, Inc. (TBHC) disclosed an amendment to a Schedule 13D showing Bed Bath & Beyond, Inc. beneficially owns 13,404,280 shares, representing 49.8% of the outstanding common stock based on 22,461,383 shares outstanding as of September 9, 2025. Bed Bath & Beyond amended its credit arrangements with the issuer on September 15, 2025, by committing to $20.0 million of delayed-draw term loan commitments evidenced by convertible Delayed Draw Notes. The Delayed Draw Notes and existing Notes can convert into 4,469,815 shares currently exercisable, equal to 19.9% of outstanding shares. The credit amendments also adjust a change-of-control threshold from 65% to 75%.